Publications by authors named "Wen Ching Han"

Claim this Profile
D
Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design.
Ashvinikumar V Gavai, Derek Norris, George Delucca, David Tortolani, John S Tokarski, Wen-Ching Han, Huiping Zhang, Yingru Zhang, Haiying Zhang

J Med Chem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to N-(Cycloalkylamino)acyl-2-aminothiazole Inhibitors of Cyclin-Dependent Kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a Highly Efficacious and Selective Antitumor Agent.
Raj N Misra, Hai-yun Xiao, Kyoung S Kim, Songfeng Lu, Wen-Ching Han, Stephanie A Barbosa, Weifang Shan

J Med Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMS-871: a novel orally active pan-Notch inhibitor as an anticancer agent.
Weifang Shan, Aaron Balog, Claude Quesnelle, Patrice Gill, Wen-Ching Han, Yingru Zhang

Bioorg Med Chem Lett· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors.
Ashvinikumar V Gavai, Claude Quesnelle, Derek Norris, Wen-Ching Han, Patrice Gill, Weifang Shan, Yingru Zhang

ACS Med Chem Lett· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists.
Hai-Yun Xiao, Aaron Balog, Ricardo M Attar, David Fairfax, Linda B Fleming, Wen-Ching Han, Weifang Shan

Bioorg Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and preclinical evaluation of [4-[[1-(3-fluorophenyl)methyl]-1H-indazol-5-ylamino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamic acid, (3S)-3-morpholinylmethyl ester (BMS-599626), a selective and orally efficacious inhibitor of human epidermal growth factor receptor 1 and 2 kinases.
Ashvinikumar V Gavai, Brian E Fink, David J Fairfax, Gregory S Martin, Lana M Rossiter, Wen-Ching Han, Shankar Swaminathan, Hongjian Zhang

J Med Chem· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
Harold Mastalerz, Ming Chang, Ping Chen, Brian E Fink, Ashvinikumar Gavai, Wen-Ching Han, Hongjian Zhang, Guifen Zhang

Bioorg Med Chem Lett· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.
Harold Mastalerz, Ming Chang, Ping Chen, Pierre Dextraze, Brian E Fink, Wen-Ching Han, Hongjian Zhang, Guifen Zhang

Bioorg Med Chem Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
Brian E Fink, Ashvinikumar V Gavai, John S Tokarski, Bindu Goyal, Raj Misra, Wen-Ching Han

Bioorg Med Chem Lett· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of the pyrrolo[2,1-f][1,2,4]triazine nucleus as a new kinase inhibitor template.
John T Hunt, Toomas Mitt, Robert Borzilleri, Johnni Gullo-Brown, Joseph Fargnoli, Wen-Ching Han

J Med Chem· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-(cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4- piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent.
Raj N Misra, Hai-yun Xiao, Kyoung S Kim, Songfeng Lu, Wen-Ching Han, Stephanie A Barbosa, Weifang Shan

J Med Chem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of aminothiazole inhibitors of cyclin-dependent kinase 2: synthesis, X-ray crystallographic analysis, and biological activities.
Kyoung Soon Kim, S David Kimball, Raj N Misra, David B Rawlins, John T Hunt, Wen-Ching Han, Weifang Shan, Chieh Ying Chang

J Med Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664.
Jagabandhu Das, S David Kimball, Steven E Hall, Wen Ching Han, Edwin Iwanowicz, Chiehying Y Chang

Bioorg Med Chem Lett· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis